HealthEquity (HQY) Q4 EPS Plunges 42.6% YoY to $0.95, Misses Estimates Despite $334.6M Revenue Beat
HealthEquity's Q4 GAAP EPS of $0.58 missed estimates by 35.4% despite revenue topping consensus, with fiscal 2027 guidance now in…
HealthEquity's Q4 GAAP EPS of $0.58 missed estimates by 35.4% despite revenue topping consensus, with fiscal 2027 guidance now in…
Titan America's Q4 EPS of $0.26 beat estimates by 6.7%, though revenue of $405.7M missed consensus as margin expansion offset…
Andersons posts $2.04 EPS, crushing estimates by 31% despite revenue miss; margins expand but cash flow turns negative in Q4…
CRDO shares dropped 10.4% to $104.73 as three analysts cut price targets following recent quarterly results, with volume 43% above…
Chemours shares jump 9.4% to $19.30 as three analyst firms raise price targets by an average of 24% over three…
GDS Holdings missed Q4 EPS estimates by 105%, posting a loss of $0.62 vs. $12.31 consensus, though revenue grew 8.6%…
BTDR shares jumped 10.1% to $9.03 on sector strength, with no company-specific catalyst as three analysts maintain Buy ratings with…
RXO shares jump 9.2% to $13.06 as Barclays, Truist, and Citigroup raise price targets, with Truist's $20 target implying 53%…
Academy Sports Q4 EPS of $1.97 missed estimates by 4% despite revenue topping consensus, sending shares down 10% on margin…
CAAP reported Q4 EPS of $0.65 vs $0.32 estimate, beating by 100.6% on revenue of $545.4M as passenger traffic rose…